InvestorsHub Logo
Followers 57
Posts 5698
Boards Moderated 0
Alias Born 12/13/2004

Re: Titan V post# 1022

Saturday, 09/17/2016 11:16:31 AM

Saturday, September 17, 2016 11:16:31 AM

Post# of 6035
"Consensus Ratings for Heat Biologics (NASDAQ:HTBX)


Ratings Breakdown: 4 Buy Ratings
Consensus Rating: Buy (Score: 3.00)
Consensus Price Target: $7.92 (469.54% upside)"

IMO a bladder partnership will bring the share price into the double digit range. A phase 3 trial in bladder is very close.

A bladder cancer partnership followed by a lung cancer partnership could again double the share price.

A complete buyout discussion would not begin at less than $30 IMO.

All these are just my opinions...feel free to disagree or share yours. Hopefully the Sept. 21 and 28 presentations will share some new information...and bring in some new investors.

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NHWK News